Share Price and Basic Stock Data
Last Updated: November 4, 2025, 5:04 pm
| PEG Ratio | 8.35 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Mohini Health & Hygiene Ltd operates within the Medical Equipment & Accessories sector, focusing on providing essential health products. The company reported a market capitalization of ₹83.9 Cr and a current share price of ₹46.0. Its revenue from operations has shown considerable variation over the years. From ₹127 Cr in FY 2019, sales rose to ₹192 Cr in FY 2023, marking a significant growth trajectory. However, FY 2025 is projected to decline to ₹168 Cr, indicating potential volatility in revenue streams. The company’s quarterly sales for Mar 2023 stood at ₹93 Cr, which increased to ₹101 Cr by Sep 2023. This upward trend in the most recent quarter reflects a positive momentum, although the subsequent quarter is expected to see a slight dip to ₹98 Cr. The overall sales growth observed over recent years highlights the company’s expanding footprint in the healthcare sector, albeit with a cautious outlook ahead.
Profitability and Efficiency Metrics
In terms of profitability, Mohini Health & Hygiene Ltd reported a net profit of ₹6 Cr for FY 2023, with a net profit margin of 3.48% for the same period. The company’s operating profit margin (OPM) was recorded at 7% for FY 2023, with a slight increase to 7% in FY 2024. Despite a robust OPM, the company has faced challenges, as seen in the fluctuating quarterly net profits, which ranged from ₹5 Cr in Sep 2023 to a lower ₹2 Cr in Mar 2023. The return on equity (ROE) stood at 10% and return on capital employed (ROCE) at 14.1%, indicating efficient utilization of shareholder funds. However, a cash conversion cycle of 127 days suggests that the company may face inefficiencies in managing its working capital. This extended period could impact liquidity and operational flexibility, necessitating strategic measures to enhance cash flows and streamline operations.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mohini Health & Hygiene Ltd demonstrates a cautious yet stable financial structure. As of Mar 2025, the company reported total borrowings of ₹35 Cr against reserves of ₹87 Cr, reflecting a conservative leverage position with a total debt-to-equity ratio of 0.32. The interest coverage ratio (ICR) stood at a solid 7.20x, indicating strong capability to meet interest obligations, which is favorable compared to many peers in the sector. Moreover, the current ratio at 2.08 signifies good short-term liquidity, ensuring that the company can cover its current liabilities comfortably. However, the inventory turnover ratio at 4.38x, while decent, suggests room for improvement in inventory management. The book value per share has increased from ₹42.70 in FY 2021 to ₹57.76 in FY 2025, reflecting a strengthening asset base and overall financial health.
Shareholding Pattern and Investor Confidence
Mohini Health & Hygiene Ltd exhibits a stable shareholding structure with promoters holding a significant 64.02% stake as of Mar 2025, which reflects strong control over the company. The public holds 34.96% of the shares, with foreign institutional investors (FIIs) and domestic institutional investors (DIIs) holding no stake, indicating a lack of institutional interest. This could suggest potential concerns about broader market confidence in the company’s growth prospects. The number of shareholders has shown a slight increase, from 737 in Mar 2025, compared to previous periods, indicating some level of growing retail interest. The absence of institutional investments might imply a need for the company to improve its visibility and attractiveness to a wider investor base. Overall, the high promoter holding can be seen as a strength, but the lack of institutional backing poses a risk to liquidity and market perception.
Outlook, Risks, and Final Insight
Looking ahead, Mohini Health & Hygiene Ltd faces both opportunities and challenges. The company’s ability to maintain revenue growth amidst projected declines in sales for FY 2025 will be critical. The fluctuating profit margins and extended cash conversion cycle present risks that could impact operational efficiency and profitability. Additionally, the lack of institutional investment could hinder the company’s ability to attract larger capital inflows necessary for expansion. On a positive note, the strong promoter backing and solid financial ratios provide a cushion against potential market volatility. To enhance its outlook, the company may need to focus on improving operational efficiencies, managing inventory better, and exploring avenues to attract institutional investors. Overall, while the company has shown resilience, strategic actions will be essential to navigate the challenging landscape of the medical equipment industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Mohini Health & Hygiene Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Constronics Infra Ltd | 80.2 Cr. | 64.0 | 158/46.0 | 19.1 | 30.9 | 0.00 % | 19.7 % | 15.8 % | 10.0 |
| Centenial Surgical Suture Ltd | 34.7 Cr. | 95.0 | 189/82.2 | 84.3 | 0.00 % | 3.94 % | 4.64 % | 10.0 | |
| Adeshwar Meditex Ltd | 27.8 Cr. | 19.2 | 26.5/15.0 | 14.0 | 25.6 | 0.00 % | 8.27 % | 5.51 % | 10.0 |
| Poly Medicure Ltd | 19,267 Cr. | 1,901 | 3,095/1,821 | 53.9 | 273 | 0.18 % | 20.1 % | 15.8 % | 5.00 |
| Mohini Health & Hygiene Ltd | 87.5 Cr. | 48.0 | 86.9/45.2 | 8.47 | 57.8 | 0.00 % | 14.1 % | 10.0 % | 10.0 |
| Industry Average | 19,267.00 Cr | 425.44 | 23.87 | 94.32 | 0.04% | 13.22% | 10.35% | 9.00 |
Quarterly Result
| Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59 | 62 | 66 | 72 | 63 | 46 | 82 | 99 | 93 | 101 | 98 | 91 | 76 |
| Expenses | 48 | 54 | 63 | 60 | 59 | 40 | 78 | 94 | 85 | 94 | 92 | 82 | 74 |
| Operating Profit | 10 | 8 | 3 | 12 | 5 | 6 | 4 | 5 | 7 | 8 | 6 | 9 | 3 |
| OPM % | 18% | 13% | 4% | 17% | 7% | 13% | 4% | 5% | 8% | 8% | 6% | 10% | 3% |
| Other Income | 0 | 0 | 6 | 0 | 0 | 1 | 6 | 6 | 0 | 4 | 4 | 1 | 3 |
| Interest | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 |
| Depreciation | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 5 | 4 | 4 | 7 | 0 | 2 | 6 | 8 | 3 | 7 | 6 | 7 | 2 |
| Tax % | 0% | 5% | 31% | 0% | 3,780% | 25% | 31% | 32% | 46% | 28% | 10% | 30% | 35% |
| Net Profit | 5 | 4 | 3 | 7 | -2 | 2 | 4 | 5 | 2 | 5 | 6 | 5 | 1 |
| EPS in Rs | 2.74 | 1.99 | 1.48 | 4.10 | -1.01 | 0.90 | 2.09 | 2.81 | 0.91 | 2.83 | 3.07 | 2.64 | 0.61 |
Last Updated: May 31, 2025, 8:24 am
Below is a detailed analysis of the quarterly data for Mohini Health & Hygiene Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Sep 2024) to 76.00 Cr., marking a decrease of 15.00 Cr..
- For Expenses, as of Mar 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.00 Cr. (Sep 2024) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 6.00 Cr..
- For OPM %, as of Mar 2025, the value is 3.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Sep 2024) to 3.00%, marking a decrease of 7.00%.
- For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Sep 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Mar 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Sep 2024) to 35.00%, marking an increase of 5.00%.
- For Net Profit, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.61. The value appears to be declining and may need further review. It has decreased from 2.64 (Sep 2024) to 0.61, marking a decrease of 2.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 91 | 122 | 137 | 148 | 127 | 128 | 135 | 127 | 192 | 200 | 168 |
| Expenses | 47 | 86 | 112 | 127 | 130 | 107 | 117 | 118 | 118 | 179 | 186 | 155 |
| Operating Profit | 2 | 5 | 10 | 10 | 17 | 20 | 11 | 17 | 9 | 13 | 14 | 12 |
| OPM % | 4% | 5% | 8% | 7% | 12% | 16% | 8% | 12% | 7% | 7% | 7% | 7% |
| Other Income | 0 | 0 | 1 | 3 | 2 | 1 | 6 | 0 | 7 | 6 | 8 | 4 |
| Interest | 1 | 1 | 4 | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 |
| Depreciation | 0 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 |
| Profit before tax | 1 | 3 | 4 | 8 | 7 | 10 | 8 | 8 | 8 | 11 | 13 | 9 |
| Tax % | 32% | 24% | 10% | 27% | 30% | 26% | 18% | 25% | 29% | 36% | 20% | 31% |
| Net Profit | 1 | 2 | 4 | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 11 | 6 |
| EPS in Rs | 2.88 | 7.62 | 15.03 | 18.83 | 2.81 | 4.21 | 3.46 | 3.09 | 2.99 | 3.72 | 5.89 | 3.25 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 8% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 100.00% | 50.00% | -16.67% | 60.00% | -25.00% | 0.00% | -16.67% | 40.00% | 57.14% | -45.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | -50.00% | -66.67% | 76.67% | -85.00% | 25.00% | -16.67% | 56.67% | 17.14% | -102.60% |
Mohini Health & Hygiene Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: June 16, 2025, 11:41 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 10 | 12 | 16 | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 |
| Borrowings | 23 | 52 | 58 | 65 | 56 | 51 | 42 | 43 | 44 | 28 | 23 | 35 |
| Other Liabilities | 5 | 18 | 11 | 18 | 20 | 16 | 19 | 22 | 22 | 21 | 17 | 28 |
| Total Liabilities | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 |
| Fixed Assets | 6 | 44 | 42 | 41 | 64 | 63 | 60 | 64 | 50 | 49 | 40 | 37 |
| CWIP | 18 | 0 | 1 | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Other Assets | 17 | 40 | 44 | 44 | 70 | 70 | 72 | 79 | 98 | 89 | 98 | 127 |
| Total Assets | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 |
Below is a detailed analysis of the balance sheet data for Mohini Health & Hygiene Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
- For Reserves, as of Mar 2025, the value is 87.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Mar 2024) to 87.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Mar 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 23.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 12.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 28.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 11.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 140.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 28.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Other Assets, as of Mar 2025, the value is 127.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2024) to 127.00 Cr., marking an increase of 29.00 Cr..
- For Total Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 28.00 Cr..
Notably, the Reserves (87.00 Cr.) exceed the Borrowings (35.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -21.00 | -47.00 | -48.00 | -55.00 | -39.00 | -31.00 | -31.00 | -26.00 | -35.00 | -15.00 | -9.00 | -23.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 133 | 49 | 64 | 89 | 82 | 65 | 60 | 112 | 67 | 72 | 39 |
| Inventory Days | 52 | 15 | 58 | 37 | 44 | 79 | 94 | 126 | 106 | 65 | 55 | 117 |
| Days Payable | 13 | 44 | 14 | 13 | 15 | 16 | 28 | 25 | 18 | 16 | 10 | 29 |
| Cash Conversion Cycle | 65 | 105 | 93 | 88 | 117 | 145 | 131 | 161 | 200 | 116 | 117 | 127 |
| Working Capital Days | 72 | 43 | 24 | 1 | 47 | 66 | 70 | 66 | 110 | 96 | 116 | 120 |
| ROCE % | 8% | 6% | 12% | 13% | 14% | 14% | 10% | 10% | 9% | 12% | 14% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
| Diluted EPS (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
| Cash EPS (Rs.) | 5.83 | 8.22 | 6.07 | 6.78 | 6.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 57.76 | 55.05 | 49.19 | 46.03 | 42.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 57.76 | 55.05 | 49.19 | 46.03 | 42.70 |
| Revenue From Operations / Share (Rs.) | 92.00 | 109.46 | 105.29 | 77.94 | 75.39 |
| PBDIT / Share (Rs.) | 12.50 | 12.00 | 10.44 | 9.59 | 9.90 |
| PBIT / Share (Rs.) | 9.88 | 9.64 | 8.10 | 6.69 | 6.90 |
| PBT / Share (Rs.) | 8.15 | 7.31 | 5.82 | 4.77 | 4.54 |
| Net Profit / Share (Rs.) | 3.21 | 5.86 | 3.72 | 3.89 | 3.39 |
| NP After MI And SOA / Share (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
| PBDIT Margin (%) | 13.58 | 10.96 | 9.91 | 12.30 | 13.13 |
| PBIT Margin (%) | 10.74 | 8.80 | 7.69 | 8.58 | 9.14 |
| PBT Margin (%) | 8.85 | 6.68 | 5.53 | 6.12 | 6.02 |
| Net Profit Margin (%) | 3.48 | 5.35 | 3.53 | 4.98 | 4.49 |
| NP After MI And SOA Margin (%) | 3.48 | 5.35 | 3.53 | 4.76 | 4.30 |
| Return on Networth / Equity (%) | 5.55 | 10.64 | 7.56 | 8.12 | 7.63 |
| Return on Capital Employeed (%) | 16.10 | 15.83 | 14.35 | 13.05 | 13.42 |
| Return On Assets (%) | 3.48 | 7.65 | 4.90 | 4.30 | 4.03 |
| Long Term Debt / Equity (X) | 0.01 | 0.05 | 0.09 | 0.06 | 0.15 |
| Total Debt / Equity (X) | 0.32 | 0.22 | 0.31 | 0.52 | 0.46 |
| Asset Turnover Ratio (%) | 1.09 | 1.44 | 1.30 | 0.93 | 0.98 |
| Current Ratio (X) | 2.08 | 3.19 | 2.43 | 1.57 | 1.47 |
| Quick Ratio (X) | 1.42 | 2.41 | 1.73 | 1.15 | 0.89 |
| Inventory Turnover Ratio (X) | 4.38 | 6.25 | 5.42 | 3.42 | 3.11 |
| Interest Coverage Ratio (X) | 7.20 | 5.16 | 4.59 | 4.99 | 4.21 |
| Interest Coverage Ratio (Post Tax) (X) | 4.86 | 3.52 | 2.64 | 3.02 | 2.44 |
| Enterprise Value (Cr.) | 129.99 | 113.80 | 119.96 | 93.74 | 79.60 |
| EV / Net Operating Revenue (X) | 0.77 | 0.57 | 0.62 | 0.65 | 0.57 |
| EV / EBITDA (X) | 5.70 | 5.20 | 6.30 | 5.36 | 4.41 |
| MarketCap / Net Operating Revenue (X) | 0.65 | 0.48 | 0.48 | 0.35 | 0.32 |
| Price / BV (X) | 1.04 | 0.95 | 1.03 | 0.60 | 0.56 |
| Price / Net Operating Revenue (X) | 0.65 | 0.48 | 0.48 | 0.35 | 0.32 |
| EarningsYield | 0.05 | 0.11 | 0.07 | 0.13 | 0.13 |
After reviewing the key financial ratios for Mohini Health & Hygiene Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 5. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 5. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.83. This value is within the healthy range. It has decreased from 8.22 (Mar 24) to 5.83, marking a decrease of 2.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.76. It has increased from 55.05 (Mar 24) to 57.76, marking an increase of 2.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.76. It has increased from 55.05 (Mar 24) to 57.76, marking an increase of 2.71.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 92.00. It has decreased from 109.46 (Mar 24) to 92.00, marking a decrease of 17.46.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 12.00 (Mar 24) to 12.50, marking an increase of 0.50.
- For PBIT / Share (Rs.), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from 9.64 (Mar 24) to 9.88, marking an increase of 0.24.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 8.15, marking an increase of 0.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.21. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.21. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For PBDIT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 10.96 (Mar 24) to 13.58, marking an increase of 2.62.
- For PBIT Margin (%), as of Mar 25, the value is 10.74. This value is within the healthy range. It has increased from 8.80 (Mar 24) to 10.74, marking an increase of 1.94.
- For PBT Margin (%), as of Mar 25, the value is 8.85. This value is below the healthy minimum of 10. It has increased from 6.68 (Mar 24) to 8.85, marking an increase of 2.17.
- For Net Profit Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 5.35 (Mar 24) to 3.48, marking a decrease of 1.87.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 8. It has decreased from 5.35 (Mar 24) to 3.48, marking a decrease of 1.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.55. This value is below the healthy minimum of 15. It has decreased from 10.64 (Mar 24) to 5.55, marking a decrease of 5.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.10. This value is within the healthy range. It has increased from 15.83 (Mar 24) to 16.10, marking an increase of 0.27.
- For Return On Assets (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 7.65 (Mar 24) to 3.48, marking a decrease of 4.17.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.32, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 1.44 (Mar 24) to 1.09, marking a decrease of 0.35.
- For Current Ratio (X), as of Mar 25, the value is 2.08. This value is within the healthy range. It has decreased from 3.19 (Mar 24) to 2.08, marking a decrease of 1.11.
- For Quick Ratio (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has decreased from 2.41 (Mar 24) to 1.42, marking a decrease of 0.99.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.38. This value is within the healthy range. It has decreased from 6.25 (Mar 24) to 4.38, marking a decrease of 1.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.20. This value is within the healthy range. It has increased from 5.16 (Mar 24) to 7.20, marking an increase of 2.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.86. This value is within the healthy range. It has increased from 3.52 (Mar 24) to 4.86, marking an increase of 1.34.
- For Enterprise Value (Cr.), as of Mar 25, the value is 129.99. It has increased from 113.80 (Mar 24) to 129.99, marking an increase of 16.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.77, marking an increase of 0.20.
- For EV / EBITDA (X), as of Mar 25, the value is 5.70. This value is within the healthy range. It has increased from 5.20 (Mar 24) to 5.70, marking an increase of 0.50.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 24) to 0.65, marking an increase of 0.17.
- For Price / BV (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 1.04, marking an increase of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 24) to 0.65, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.05, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mohini Health & Hygiene Ltd:
- Net Profit Margin: 3.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.1% (Industry Average ROCE: 13.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.55% (Industry Average ROE: 10.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.86
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.47 (Industry average Stock P/E: 23.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Medical Equipment & Accessories | Plot No 109, Sector 3, Dhar Madhya Pradesh 454774 | cs@mohinihealthandhygiene.com, http://www.mohinihealthandhygiene.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Avnish Bansal | Managing Director |
| Mr. Viral Patel | Executive Director |
| Mr. Sarvapriya Bansal | Whole Time Director |
| Mrs. Parul Agarwal | Whole Time Director |
| Mr. Mukesh Vyas | Ind. Non-Executive Director |
| Mr. Chandrashekhar Bobra | Ind. Non-Executive Director |
| Mr. Mukul Jain | Ind. Non-Executive Director |
| Mr. Mahesh Fogla | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mohini Health & Hygiene Ltd?
Mohini Health & Hygiene Ltd's intrinsic value (as of 06 November 2025) is 39.95 which is 16.77% lower the current market price of 48.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 87.5 Cr. market cap, FY2025-2026 high/low of 86.9/45.2, reserves of ₹87 Cr, and liabilities of 168 Cr.
What is the Market Cap of Mohini Health & Hygiene Ltd?
The Market Cap of Mohini Health & Hygiene Ltd is 87.5 Cr..
What is the current Stock Price of Mohini Health & Hygiene Ltd as on 06 November 2025?
The current stock price of Mohini Health & Hygiene Ltd as on 06 November 2025 is 48.0.
What is the High / Low of Mohini Health & Hygiene Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mohini Health & Hygiene Ltd stocks is 86.9/45.2.
What is the Stock P/E of Mohini Health & Hygiene Ltd?
The Stock P/E of Mohini Health & Hygiene Ltd is 8.47.
What is the Book Value of Mohini Health & Hygiene Ltd?
The Book Value of Mohini Health & Hygiene Ltd is 57.8.
What is the Dividend Yield of Mohini Health & Hygiene Ltd?
The Dividend Yield of Mohini Health & Hygiene Ltd is 0.00 %.
What is the ROCE of Mohini Health & Hygiene Ltd?
The ROCE of Mohini Health & Hygiene Ltd is 14.1 %.
What is the ROE of Mohini Health & Hygiene Ltd?
The ROE of Mohini Health & Hygiene Ltd is 10.0 %.
What is the Face Value of Mohini Health & Hygiene Ltd?
The Face Value of Mohini Health & Hygiene Ltd is 10.0.